ARTV fundamentals
An in-depth look to Artiva Biotherapeutics, Inc. operating, investing, and financing activities
ARTV free cash flow for Q3 24 is -11.71 M USD. For 2023, ARTV free cash flow was -50.69 M USD and operating cash flow was -47.43 M USD.
Q4 '20
Q1 '21
Q4 '21
Q1 '22
Q1 '23
Q3 '23
Q1 '24
Q2 '24
Q3 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q4 '20
Q1 '21
Q4 '21
Q1 '22
Q1 '23
Q3 '23
Q1 '24
Q2 '24
Q3 '24
TTM